Related references
Note: Only part of the references are listed.Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication
Hannu Uusitalo et al.
ACTA OPHTHALMOLOGICA (2010)
Effects of Benzalkonium Chloride-Preserved, Polyquad-Preserved, and sofZia-Preserved Topical Glaucoma Medications on Human Ocular Epithelial Cells
David A. Ammar et al.
ADVANCES IN THERAPY (2010)
Prevalence of Ocular Surface Complaints in Patients With Glaucoma Using Topical Intraocular Pressure-Lowering Medications
Robert D. Fechtner et al.
CORNEA (2010)
Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial
Arthur Shedden et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Treatment of glaucoma in patients with dry eye syndrome
A. Labbe et al.
JOURNAL FRANCAIS D OPHTALMOLOGIE (2010)
Preservatives in eyedrops: The good, the bad and the ugly
Christophe Baudouin et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
Screening for Meibomian Gland Disease: Its Relation to Dry Eye Subtypes and Symptoms in a Tertiary Referral Clinic in Singapore
Louis Tong et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
The management of allergic eye diseases in primary eye care
DeGaulle I. Chigbu
CONTACT LENS & ANTERIOR EYE (2009)
Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears
Malik Y. Kahook et al.
CORNEA (2008)
In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line
Emmanuelle Brasnu et al.
CURRENT EYE RESEARCH (2008)
German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye
Carl Erb et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Prevalence of ocular surface disease in glaucoma patients
Eamon W. Leung et al.
JOURNAL OF GLAUCOMA (2008)
The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways
Christophe Baudouin et al.
OPHTHALMOLOGY (2008)
Clinical grading of atopic keratoconjunctivitis
Margarita Calonge et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Ocular comfort of combination glaucoma therapies: Brimonidine 0.2%/timolol 0.5% compared with dorzolamide 2%/timolol 0.5%
Kenny Chan et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Neighboring forms of allergy
C. Baudouin
JOURNAL FRANCAIS D OPHTALMOLOGIE (2007)
Comparison of tobramycin 0.3%/dexamethasone 0.1% and tobramycin 0.3%/loteprednol 0.5% in the management of blepharo-keratoconjunctivitis
Steven S. Rhee et al.
ADVANCES IN THERAPY (2007)
Incidence and prevalence of glaucoma in severe ocular surface disease
Julie H. Tsai et al.
CORNEA (2006)
Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment
SJ Ono et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Corneal and conjunctival changes caused by commonly used glaucoma medications
RJ Noecker et al.
CORNEA (2004)
Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study
PJ Pisella et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
In vitro effects of preserved and unpreserved antiglaucoma drugs on apoptotic marker expression by human trabecular cells
P Hamard et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2003)
In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system
C Blondin et al.
CURRENT EYE RESEARCH (2003)
Evaluation of the comfort of Alphagan (R) P compared with Alphagan (R) in irritated eyes
T Mundorf et al.
ADVANCES IN THERAPY (2003)
Share Paper
